中华肾脏病杂志
中華腎髒病雜誌
중화신장병잡지
2013年
6期
413-418
,共6页
姜物华%丁小强%方艺%刘岚%王春生%滕杰
薑物華%丁小彊%方藝%劉嵐%王春生%滕傑
강물화%정소강%방예%류람%왕춘생%등걸
心脏外科手术%肾替代疗法%急性肾损伤%预测模型%验证
心髒外科手術%腎替代療法%急性腎損傷%預測模型%驗證
심장외과수술%신체대요법%급성신손상%예측모형%험증
Cardiac surgical procedures%Renal replacement therapy%Acute kidney injury%Predicting models%Validation
目的 研究AKICS、Cleveland、SRI、Mehta和EURO评分模型在心脏外科手术后急性肾损伤(AKI)、需肾脏替代治疗的AKI (RRT-AKI)和死亡的预测价值,比较不同模型的预测能力.方法 连续收集2010年5月至2011年1月在复旦大学附属中山医院接受心脏外科手术的患者1067例,分别评价5种评分模型对术后AKI(AKICS评分)、RRT-AKI(Cleveland、SRI和Mehta评分)和死亡(EURO评分)的预测价值,以分辨力(操作者曲线下面积,AUROC)和校准度(Hosmer-Lemeshow拟合优度检验)表示.结果 1067例患者中发生AKI 217例(20.34%),其中137例(63.13%)治疗后肾功能完全恢复;RRT-AKI 38例(3.56%);AKI和RRT-AKI患者的病死率分别为9.68% (21/217)和44.73%(17/38),总体病死率为3.28%(35/1067).预测AKI方面,AKICS模型的分辨力和校准度均较低.预测RRT-AKI方面,Cleveland模型的分辨力和校准度均达到要求,但RRT-AKI的预测值明显低于实际值(1.70%比3.86%),MeSa模型的分辨力较低,而SRI模型的校准度较低.EURO模型预测死亡的分辨力和校准度均较低.结论 按照目前AKI诊断标准,上述5种模型均不能准确预测心脏外科手术后AKI的发生.Cleveland模型在预测RRT-AKI方面有一定作用,但预测值与实际值仍然有较大差别.EURO评分不能准确预测死亡风险.
目的 研究AKICS、Cleveland、SRI、Mehta和EURO評分模型在心髒外科手術後急性腎損傷(AKI)、需腎髒替代治療的AKI (RRT-AKI)和死亡的預測價值,比較不同模型的預測能力.方法 連續收集2010年5月至2011年1月在複旦大學附屬中山醫院接受心髒外科手術的患者1067例,分彆評價5種評分模型對術後AKI(AKICS評分)、RRT-AKI(Cleveland、SRI和Mehta評分)和死亡(EURO評分)的預測價值,以分辨力(操作者麯線下麵積,AUROC)和校準度(Hosmer-Lemeshow擬閤優度檢驗)錶示.結果 1067例患者中髮生AKI 217例(20.34%),其中137例(63.13%)治療後腎功能完全恢複;RRT-AKI 38例(3.56%);AKI和RRT-AKI患者的病死率分彆為9.68% (21/217)和44.73%(17/38),總體病死率為3.28%(35/1067).預測AKI方麵,AKICS模型的分辨力和校準度均較低.預測RRT-AKI方麵,Cleveland模型的分辨力和校準度均達到要求,但RRT-AKI的預測值明顯低于實際值(1.70%比3.86%),MeSa模型的分辨力較低,而SRI模型的校準度較低.EURO模型預測死亡的分辨力和校準度均較低.結論 按照目前AKI診斷標準,上述5種模型均不能準確預測心髒外科手術後AKI的髮生.Cleveland模型在預測RRT-AKI方麵有一定作用,但預測值與實際值仍然有較大差彆.EURO評分不能準確預測死亡風險.
목적 연구AKICS、Cleveland、SRI、Mehta화EURO평분모형재심장외과수술후급성신손상(AKI)、수신장체대치료적AKI (RRT-AKI)화사망적예측개치,비교불동모형적예측능력.방법 련속수집2010년5월지2011년1월재복단대학부속중산의원접수심장외과수술적환자1067례,분별평개5충평분모형대술후AKI(AKICS평분)、RRT-AKI(Cleveland、SRI화Mehta평분)화사망(EURO평분)적예측개치,이분변력(조작자곡선하면적,AUROC)화교준도(Hosmer-Lemeshow의합우도검험)표시.결과 1067례환자중발생AKI 217례(20.34%),기중137례(63.13%)치료후신공능완전회복;RRT-AKI 38례(3.56%);AKI화RRT-AKI환자적병사솔분별위9.68% (21/217)화44.73%(17/38),총체병사솔위3.28%(35/1067).예측AKI방면,AKICS모형적분변력화교준도균교저.예측RRT-AKI방면,Cleveland모형적분변력화교준도균체도요구,단RRT-AKI적예측치명현저우실제치(1.70%비3.86%),MeSa모형적분변력교저,이SRI모형적교준도교저.EURO모형예측사망적분변력화교준도균교저.결론 안조목전AKI진단표준,상술5충모형균불능준학예측심장외과수술후AKI적발생.Cleveland모형재예측RRT-AKI방면유일정작용,단예측치여실제치잉연유교대차별.EURO평분불능준학예측사망풍험.
Objective To assess the clinical usefulness and value of the 5 models for the prediction of acute kidney injury (AKI),severe AKI which renal replacement treatment was needed (RRT-AKI) and death after cardiac surgery procedures in Chinese patients.Methods One thousand and sixty-seven patients who underwent cardiac surgery procedures in the department of cardiac surgery in the Zhongshan Hospital,Fudan University between May 2010 and January 2011 were involved in this research.The predicting value for AKI (AKICS),RRT-AKI (Cleveland,SRI and Mehta score) and death (EURO score) after cardiac surgery procedures was evaluated by Hosmer-Lemeshow goodness-of-fit test for the calibration and area under receiver operation characteristic curve (AUROC)for the discrimination.Results The incidence of AKI was 20.34%(217/1067),and 63.13% of their renal function recovered completely.The incidence of RRT-AKI was 3.56%(38/1067) and the mortality of AKI and RRT-AKI was 9.68% (21/217) and 44.73% (17/38) respectively.The total mortality was 3.28% (35/1067).The discrimination and calibration for the prediction ofAKI of AKICS were low.For the prediction ofRRT-AKI,the discrimination and calibration of Cleveland score were high enough,but the predicated value was lower than the real value (1.70% vs 3.86%).The discrimination of Mehta score and the calibration of SRI were low.The discrimination and calibration for the prediction of death of EURO score was low.Conclusion According to the 2012 KDIGO AKI definition,none of the 5 models above is good at predicting AKI after cardiac surgery procedures.Cleveland score has been validated to have a proper impact on predicting RRT-AKI after cardiac surgery procedures,but the predicting value is still in doubt.EURO score has been validated to have an inaccurate predicting value for death after cardiac surgery procedures.